Hyunjae D. Shin - Publications

Correspondence to editorial 2 on "Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis".

Journal: Clinical and molecular hepatology

Published: January 09, 2026

Correspondence to editorial 1 on "Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis".

Journal: Clinical and molecular hepatology

Published: January 09, 2026

Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial.

Journal: Cancer immunology, immunotherapy : CII

Published: November 18, 2025

Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B: A Multicenter Randomized Trial in Korea.

Journal: Gut and liver

Published: September 29, 2025

The Liver Week 2025 Highlights: Celebrating the 30th Anniversary of the Korean Association for the Study of the Liver.

Journal: Clinical and molecular hepatology

Published: September 17, 2025

Correction: Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: August 22, 2025

Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis.

Journal: Diagnostic and interventional imaging

Published: July 16, 2025

Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis.

Journal: Clinical and molecular hepatology

Published: May 19, 2025

Adverse Event Monitoring with Imaging: Prognostic Significance in Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma.

Journal: Liver cancer

Published: April 15, 2025

Hepatocellular carcinoma in Korea: an analysis of the 2016-2018 Korean Nationwide Cancer Registry.

Journal: Journal of liver cancer

Published: January 26, 2025

Comparison of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Steatotic Liver Disease.

Journal: Gut and liver

Published: December 25, 2024

A concise review of updated global guidelines for the management of hepatocellular carcinoma: 2017-2024.

Journal: Journal of liver cancer

Published: December 25, 2024